{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:15:21Z","timestamp":1780352121311,"version":"3.54.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejso.2024.108387","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:07:20Z","timestamp":1715310440000},"page":"108387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-6462","authenticated-orcid":false,"given":"Johnn Henry","family":"Herrera Kok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-9588","authenticated-orcid":false,"given":"Luigi","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9930-5020","authenticated-orcid":false,"given":"Preethi","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Vashist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-0383","authenticated-orcid":false,"given":"Laura","family":"Lorenzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-6907","authenticated-orcid":false,"given":"Beate","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-261X","authenticated-orcid":false,"given":"Richard","family":"van Hillegersberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"de Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Spallanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-7790","authenticated-orcid":false,"given":"Won Jun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-4929","authenticated-orcid":false,"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-1696","authenticated-orcid":false,"given":"Karen","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Solaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas PL.","family":"Wijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-6880","authenticated-orcid":false,"given":"Francesco","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Chevallay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2168-6534","authenticated-orcid":false,"given":"Eunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ejso.2024.108387_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ejso.2021.10.003","article-title":"ESSO core curriculum committee update on surgical oncology","volume":"47","author":"Van der Hage","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108387_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ejso.2016.04.004","article-title":"Variations in training of surgical oncologists: proposal for a global curriculum","volume":"42","author":"Are","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108387_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1245\/s10434-016-5194-3","article-title":"Fighting global disparities in cancer care: a surgical oncology view","volume":"23","author":"Hoekstra","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.21614\/chirurgia.112.4.365","article-title":"How can we improve education of breast surgeons across Europe?","volume":"112","author":"Kolacinska","year":"2017","journal-title":"Chirurgia (buck)"},{"key":"10.1016\/j.ejso.2024.108387_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fonc.2018.00346","article-title":"Global inequities in precision medicine and molecular cancer research","volume":"8","author":"Drake","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib7","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1016\/j.ejso.2017.07.018","article-title":"Global variations in the level of cancer-related research activity and correlation to cancer-specific mortality: proposal for a global curriculum","volume":"44","author":"Are","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ejso.2019.01.003","article-title":"Variability in breast cancer surgery training across Europe: an ESSO-EUSOMA international survey","volume":"45","author":"Rubio","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2024.108387_bib9","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1245\/s10434-021-10274-w","article-title":"Cultural complications curriculum: applicability to surgical oncology programs and practices","volume":"28","author":"Baskin","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2024.108387_bib10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s11605-021-05019-9","article-title":"Training paradigms in hepato-pancreatico-biliary surgery: an overview of the different fellowship pathways","volume":"25","author":"Jeyarajah","year":"2021","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejso.2022.09.012","article-title":"Study protocol for the oligometastatic esophagogastric cancer (OMEC) project: a multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer","volume":"49","author":"Kroese","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108387_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","article-title":"Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Ajani","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2024.108387_bib14","doi-asserted-by":"crossref","first-page":"v50e7","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108387_bib15","first-page":"1517e632","article-title":"S3-Leitlinie Magenkarzinom- Diagnostik und Therapie der Adenokarzinome des Magens und des o\u20acsophagogastralen \u00dcbergangs","volume":"57","author":"Moehler","year":"2019","journal-title":"Z\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12885-017-3918-9","article-title":"The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III tri","volume":"17","author":"Al-Batran","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib17","article-title":"Testing the addition of radiotherapy to the usual treatment (chemotherapy) for patients with esophageal and gastric cancer that has spread to a limited number of other places in the body","year":"2020","journal-title":"clinicaltrials.gov\/NCT04248452"},{"key":"10.1016\/j.ejso.2024.108387_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-018-4034-1","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial","volume":"18","author":"Noordman","year":"2018","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2024.108387_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ejso.2018.02.208","article-title":"Synchronous metastatic gastric cancer molecular background and clinical implications with special attention to mismatch repair deficiency","volume":"44","author":"Polom","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1245\/s10434-015-4958-5","article-title":"Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery","volume":"23","author":"Marmor","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108387_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10120-011-0069-6","article-title":"How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis","author":"Seevaratnam","year":"2012","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-230X-11-19","article-title":"Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review","volume":"11","author":"Wang","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108387_bib23","series-title":"Gastric cancer: the 25-year R-Evolution","first-page":"67","article-title":"Chapter 8: the role of staging laparoscopy","author":"Solaini","year":"2021"},{"key":"10.1016\/j.ejso.2024.108387_bib24","doi-asserted-by":"crossref","unstructured":"Ministrini S, Bencivenga M, Solaini L, et\u00a0al. Stage IV gastric cancer: the surgical perspective of the Italian research group on gastric cancer. Cancers (Basel) 202;12(1):158. doi: 10.3390\/cancers12010158. PMID: 31936512. PMCID: PMC7016536.","DOI":"10.3390\/cancers12010158"},{"key":"10.1016\/j.ejso.2024.108387_bib25","doi-asserted-by":"crossref","unstructured":"Yoshida K, Yasufuku I, Terashima M, et\u00a0al. International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1). Ann Gastroenterol Surg 6:227-240. doi: 10.1002\/ags3.12515. PMID: 35261948. PMCID: PMC8889854.","DOI":"10.1002\/ags3.12515"},{"issue":"9","key":"10.1016\/j.ejso.2024.108387_bib26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108387_bib28","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1007\/s10120-011-0047-z","article-title":"A\u00a0systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer","author":"Leake","year":"2012","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199703000-00004","article-title":"Laparoscopy in the management of gastric adenocarcinoma","volume":"225","author":"Burke","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib30","doi-asserted-by":"crossref","unstructured":"Solaini L, Bencivenga M, Marrelli D,et\u00a0al. The role of staging laparoscopy in stage cM+ gastric cancer patients. Eur J Surg Oncol, Volume 50, Issue 2, 107408. DOI:https:\/\/doi.org\/10.1016\/j.ejso.2023.107408.","DOI":"10.1016\/j.ejso.2023.107408"},{"issue":"8","key":"10.1016\/j.ejso.2024.108387_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jso.23328","article-title":"Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer","volume":"107","author":"Mezhir","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-024-03034-z","article-title":"Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid","author":"Van der Sluis","year":"2024","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10120-019-00994-0","article-title":"Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy","volume":"23","author":"Yasufuku","year":"2020","journal-title":"Gastric Cancer"},{"issue":"19","key":"10.1016\/j.ejso.2024.108387_bib34","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III Trial comparing intraperitoneal and intravenous Paclitaxel plus S-1 versus Cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2024.108387_bib35","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1245\/s10434-022-11998-z","article-title":"Outcomes of a Phase II Study of intraperitoneal Paclitaxel plus systemic Capecitabine and Oxaliplatin (XELOX) for gastric cancer with peritoneal metastases","volume":"29","author":"Chia","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5230\/jgc.2021.21.e38","article-title":"Intraperitoneal Paclitaxel combined with S-1 plus Oxaliplatin for advanced gastric cancer with peritoneal metastasis","volume":"21","author":"Kim","year":"2021","journal-title":"J\u00a0Gastric Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib37","unstructured":"Seo WJ, et\u00a0al. The role of intraperitoneal Paclitaxel plus systemic S1 plus Oxaliplatin for gastric cancer with peritoneal metastases. Department of Surgery, Korea University Guro Hospital. Seoul, Republic of Korea. IRB2019GR0459. Seoul, Korea."},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib38","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0116","article-title":"PIPAC EstoK 01: pressurized intraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: a randomized and multi center phase II study","volume":"3","author":"Eveno","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"11","key":"10.1016\/j.ejso.2024.108387_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2024.108387_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103846","article-title":"Pressurized intraperitoneal aerosolised chemotherapy (PIPAC) for gastric cancer with peritoneal metastases: a systematic review by the PIPAC UK collaborative","volume":"180","author":"Case","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib41","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/cancers15041125","article-title":"10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis","volume":"15","author":"Di Giorgio","year":"2023","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.ejso.2024.108387_bib42","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.3748\/wjg.v29.i24.3758","article-title":"Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: a narrative review","volume":"29","author":"Shoji","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108387_bib43","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12885-020-07152-1","article-title":"The CARDIA-TRIAL protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II","volume":"20","author":"Leers","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12885-022-09375-w","article-title":"The abdominal-transhiatal surgical approach versus the thoracoabdominal approach in Siewert type II adenocarcinoma of the esophagogastric junction: protocol for a multicenter prospective, open, parallel, and randomized controlled trial","volume":"22","author":"Song","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SLA.0000000000003499","article-title":"Mapping of lymph node metastasis from esophagogastric junction tumors: a prospective nationwide multicenter study","volume":"274","author":"Kurokawa","year":"2021","journal-title":"Ann Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108387_bib47","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1007\/s10120-016-0663-8","article-title":"Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma","volume":"20","author":"Yamashita","year":"2017","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2024.108387_bib48","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1245\/s10434-014-3548-2","article-title":"Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor","volume":"21","author":"Mine","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib49","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10120-023-01369-2","article-title":"Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer","volume":"26","author":"Koterazawa","year":"2023","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13304-019-00665-w","article-title":"Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature","volume":"71","author":"Niclauss","year":"2019","journal-title":"Updates Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib51","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00423-021-02375-7","article-title":"Optimal surgery for esophagogastric junctional cancer","volume":"407","author":"Hayashi","year":"2022","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.14454","article-title":"Current surgical treatment standards for esophageal and esophagogastric junction cancer","volume":"1482","author":"Jung","year":"2020","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5230\/jgc.2018.18.e28","article-title":"Surgical treatment of gastroesophageal junction cancer","volume":"18","author":"Hashimoto","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib54","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/cancers15092597","article-title":"Management of esophago-gastric junction carcinoma: a narrative multidisciplinary review","volume":"15","author":"Tondolo","year":"2023","journal-title":"Cancers"},{"issue":"31","key":"10.1016\/j.ejso.2024.108387_bib55","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.3748\/wjg.v28.i31.4299","article-title":"Recent advances in multidisciplinary therapy for adenocarcinoma of the esophagus and esophagogastric junction","volume":"28","author":"Zheng","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108387_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/bjs.1800691019","article-title":"The mesorectum in rectal cancer surgery: the clue to pelvic recurrence?","volume":"69","author":"Heald","year":"1982","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1463-1318.2008.01735.x","article-title":"Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome","volume":"11","author":"Hohenberger","year":"2009","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2024.108387_bib58","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jamcollsurg.2015.02.037","article-title":"Tracing dissectable layers of mesenteries overcomes embryologic restrictions when performing infrapyloric lymphadenectomy in laparoscopic gastric cancer surgery","volume":"220","author":"Shinohara","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib59","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00464-018-6111-6","article-title":"Outermost layer-oriented medial approach for infrapyloric nodal dissection in laparoscopic distal gastrectomy","volume":"32","author":"Shibazaki","year":"2018","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2024.108387_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00423-019-01770-5","article-title":"Laparoscopic modified lymphadenectomy in gastric cancer surgery using systematic mesogastric excision: a novel technique based on a concept","volume":"404","author":"Kumamoto","year":"2019","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/bjs.5240","article-title":"Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma","volume":"93","author":"Etoh","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib62","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/bjs.10881","article-title":"Detection of carcinoembryonic antigen in peritoneal fluid of patients undergoing laparoscopic distal gastrectomy with complete mesogastric excision","volume":"105","author":"Xie","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2024.108387_bib63","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0037-1606109","article-title":"The perfect total mesorectal excision obviates the need for anything else in the management of most rectal cancers","volume":"30","author":"Heald","year":"2017","journal-title":"Clin Colon Rectal Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib64","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/SLA.0000000000003031","article-title":"Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial","volume":"269","author":"Van der Sluis","year":"2019","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1442-2050.2008.00929.x","article-title":"International survey on esophageal cancer: Part I Surgical techniques","volume":"22","author":"Boone","year":"2009","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib66","first-page":"1","article-title":"Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophagel junction cancer","volume":"30","author":"Haverkamp","year":"2017","journal-title":"Dis Esophagus"},{"issue":"7","key":"10.1016\/j.ejso.2024.108387_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doac099","article-title":"Trends in surgical techniques for the treatment of esophageal and gastroesophageal junction cancer","volume":"36","author":"De Groot","year":"2022","journal-title":"Dis Esophagus"},{"issue":"Supplement_2","key":"10.1016\/j.ejso.2024.108387_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doaa066","article-title":"A\u00a0standardized approach for the thoracic dissection in robotic-assisted minimally invasive esophaguectomy (RAMIE)","volume":"33","author":"Kingma","year":"2020","journal-title":"Dis Esophagus"},{"issue":"5","key":"10.1016\/j.ejso.2024.108387_bib69","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s13304-021-01059-7","article-title":"Robotic versus laparoscopic gastrectomy for gastric cancer: an umbrella review of systematic reviews and meta-analysis","volume":"73","author":"Marano","year":"2021","journal-title":"Updates Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib70","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s10120-022-01288-8","article-title":"Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis","volume":"25","author":"Shibasaki","year":"2022","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107406","article-title":"Surgical outcomes of robotic vs laparoscopic total gastrectomy: a single-center retrospective cohort study using propensity-score matching analysis","volume":"50","author":"Nagata","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib72","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00464-021-08483-1","article-title":"Reduction in postoperative complications by robotic surgery: a case-control study of robotic versus conventional laparoscopic surgery for gastric cancer","volume":"36","author":"Kinoshita","year":"2022","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annonc.2021.09.005","article-title":"Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"33","author":"Casali","year":"2022","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108387_bib74","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4143\/crt.2016.187","article-title":"Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor","volume":"48","author":"Koo","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"17","key":"10.1016\/j.ejso.2024.108387_bib75","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.3390\/cancers13174351","article-title":"Minimally invasive approach to gastric GISTs: analysis of a multicenter robotic and laparoscopic experience with literature review","volume":"13","author":"Ceccarelli","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/rcs.2198","article-title":"Open versus laparoscopic versus robotic gastric gastrointestinal stromal tumour resections: a multicentre cohort study","volume":"17","author":"Solaini","year":"2021","journal-title":"Int J Med Robot"},{"issue":"7","key":"10.1016\/j.ejso.2024.108387_bib77","first-page":"2708","article-title":"Current trends in volume and surgical outcomes in gastric cancer","volume":"12","author":"Marano","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107404","article-title":"Laparoscopic versus robotic partial gastrectomy for gastrointestinal stromal tumor: preliminary results","volume":"50","author":"Brasset","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108387_bib79","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/bjs.10486","article-title":"Textbook outcome as a composite measure in oesophagogastric cancer surgery","volume":"104","author":"Busweiler","year":"2017","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.108387_bib80","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/bjs.10729","article-title":"Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery","volume":"105","author":"Van der Kaaij","year":"2018","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib81","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10120-019-01015-w","article-title":"Gastrectomy case volume and textbook outcome: an analysis of the population Registry of esophageal and stomach tumours of ontatio (PRESTO)","volume":"23","author":"Levy","year":"2020","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib82","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/SLA.0000000000003849","article-title":"Textbook outcome and survival in patients with gastric cancer: an analysis of the population Registry of esophageal and stomach tumours of Ontario (PRESTO)","volume":"275","author":"Levy","year":"2022","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2024.108387_bib83","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0000000000004341","article-title":"Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA Registry: a European Retrospective Observational Study","volume":"272","author":"Baiocchi","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib85","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12877-017-0569-2","article-title":"The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis","volume":"17","author":"Shen","year":"2017","journal-title":"BMC Geriatr"},{"issue":"7","key":"10.1016\/j.ejso.2024.108387_bib86","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamasurg.2014.241","article-title":"Multidimensional frailty score for the prediction of postoperative mortality risk","volume":"149","author":"Kim","year":"2014","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107405","article-title":"The impact of frailty and sarcopenia on postoperative outcomes in elderly gastric cancer patients undergoing gastrectomy","volume":"50","author":"Lee","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2024.108387_bib88","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108387_bib89","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/SLA.0000000000004930","article-title":"Chemoradiotherapy followed by active surveillance versus standard esophagectomy for esophageal cancer: a systematic review and individual patient data meta-analysis","volume":"275","author":"Van der Wilk","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib90","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/SLA.0000000000003397","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis","volume":"271","author":"Eyck","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib91","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12885-020-6669-y","article-title":"Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib92","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113370","article-title":"Treatment of gastric adenocarcinoma: a rapidly evolving landscape","volume":"195","author":"Taieb","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib94","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221083049","article-title":"The dawn of precision medicine in diffuse-type gastric cancer","volume":"14","author":"Ooki","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib95","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.annonc.2021.02.005","article-title":"FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastroesophageal adenocarcinoma","volume":"32","author":"Sahin","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-022-00385-1","article-title":"Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy","volume":"10","author":"Cao","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.ejso.2024.108387_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","article-title":"Predictive biomarkers in gastric cancer","volume":"149","author":"R\u00f6cken","year":"2023","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib98","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S1470-2045(22)00603-9","article-title":"Bemarituzumab in patients with FGFR2-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study","volume":"23","author":"Wainberg","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib99","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1200\/JCO.2020.38.15_suppl.4537","article-title":"The association of tissue tumor mutational burden (tTMB) using the Foundation Medicine genomic platform with efficacy of pembrolizumab versus paclitaxel in patients (pts) with gastric cancer (GC) from KEYNOTE-061","volume":"38","author":"Shitara","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion positive tumors from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib101","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib102","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jclinpath-2018-205679","article-title":"Testing algorithm for identification of patients with NTRK fusion cancer","volume":"72","author":"Penault-Llorca","year":"2019","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ejso.2024.108387_bib103","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.ejso.2024.108387_bib104","doi-asserted-by":"crossref","first-page":"S1045","DOI":"10.1016\/j.annonc.2021.08.1490","article-title":"1381P adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC\/GEJC) following neoadjuvante chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577","volume":"32","author":"Moehler","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib105","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2022.40.16_suppl.4003","volume":"40","author":"Al-Batran","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib106","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1200\/JCO.19.01124","article-title":"Individual patient data meta-analysis of the value of micro satellite instability as a biomarker in gastric cancer","volume":"37","author":"Pietrantonio","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.22.00686","article-title":"Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: the GERCOR NEONIPIGA phase II study","volume":"41","author":"Andr\u00e9","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108387_bib108","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3390\/cancers13112839","article-title":"Tremelimumab and durvalumab combination for the non-operative management (NOM) of micro satellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer: the multicentre, single-arm, multi cohort, phase II INFINITY study","volume":"13","author":"Raimondi","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejso.2024.108387_bib109","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41591-023-02758-x","article-title":"Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial","volume":"30","author":"Verschoor","year":"2024","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ejso.2024.108387_bib110","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"oEsophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108387_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese gastric cancer treatment guidelines 2021 (6th edition)","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib112","article-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae)","year":"12024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ejso.2024.108387_bib113","series-title":"Esophageal and esophagogastric junction cancers","article-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae)","year":"12024"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T23:55:43Z","timestamp":1719705343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":113,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0748798324004396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108387","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108387"}}